Steven G Griffiths

Title: The Innovative Contributions of Steven G Griffiths

Introduction

Steven G Griffiths is a notable inventor based in Moncton, Canada. He has made significant contributions to the field of biomedical research, particularly in the area of tumor-derived microparticles. His work focuses on the use of specific biomarkers to enhance the understanding and analysis of cancer-related conditions.

Latest Patents

Griffiths holds a patent titled "Use of Tenascin-C as an extracellular marker of tumor-derived microparticles." This patent outlines methods for isolating tumor-derived microparticles from a subject for analysis. Specifically, it details the process of isolating Tenascin-C positive microparticles from a sample to obtain tumor-derived microparticles. The patent also includes methods for determining the expression status of biomarkers in these microparticles and for assessing additional characteristics of the tumor-derived microparticles.

Career Highlights

Griffiths is associated with Nx Pharmagen, a company that focuses on innovative solutions in the pharmaceutical and biotechnology sectors. His work at Nx Pharmagen has allowed him to contribute to advancements in cancer research and diagnostics.

Collaborations

One of his notable collaborators is Alan M Ezrin. Their partnership has likely fostered innovative approaches to research and development in their field.

Conclusion

Steven G Griffiths exemplifies the spirit of innovation in the biomedical field through his patent and work at Nx Pharmagen. His contributions are paving the way for improved cancer diagnostics and treatment methodologies.